BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,905,000 | +1.4% | 6,730,000 | +5.7% | 0.54% | -3.7% |
| Q4 2020 | $6,807,000 | +1.7% | 6,370,000 | -0.2% | 0.56% | -8.9% |
| Q3 2020 | $6,691,000 | -17.3% | 6,385,000 | -3.3% | 0.62% | -25.1% |
| Q2 2020 | $8,086,000 | +15.9% | 6,605,000 | -1.9% | 0.83% | +0.1% |
| Q1 2020 | $6,977,000 | -29.6% | 6,730,000 | -28.4% | 0.83% | -11.7% |
| Q4 2019 | $9,915,000 | +5.1% | 9,405,000 | -1.2% | 0.94% | -4.7% |
| Q3 2019 | $9,430,000 | +2.0% | 9,520,000 | +6.7% | 0.98% | -4.8% |
| Q2 2019 | $9,242,000 | +3.4% | 8,925,000 | +2.1% | 1.03% | -5.6% |
| Q1 2019 | $8,935,000 | +23.2% | 8,745,000 | +19.8% | 1.09% | +4.0% |
| Q4 2018 | $7,250,000 | -7.0% | 7,300,000 | -1.2% | 1.05% | -2.3% |
| Q3 2018 | $7,792,000 | +3.0% | 7,390,000 | -0.9% | 1.08% | -7.7% |
| Q2 2018 | $7,568,000 | -99.9% | 7,455,000 | +5.0% | 1.17% | +9.8% |
| Q1 2018 | $6,681,214,000 | +20.1% | 7,100,000 | +27.4% | 1.06% | +18.8% |
| Q4 2017 | $5,562,541,000 | +10.6% | 5,575,000 | +12.6% | 0.90% | +2.5% |
| Q3 2017 | $5,029,596,000 | – | 4,950,000 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 29,791,000 | $29,160,000 | 1.77% |
| PFM Health Sciences, LP | 45,910,000 | $45,566,000 | 1.74% |
| Cheyne Capital Management (UK) LLP | 1,500,000 | $1,486,000 | 1.26% |
| SSI INVESTMENT MANAGEMENT LLC | 11,878,000 | $11,761,000 | 0.74% |
| Sonora Investment Management Group, LLC | 6,550,000 | $6,527,000 | 0.62% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 34,005,000 | $33,750,000 | 0.60% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,703,000 | $10,595,000 | 0.29% |
| MACKAY SHIELDS LLC | 11,419,000 | $11,304,000 | 0.27% |
| BNP Paribas Asset Management Holding S.A. | 4,175,000 | $70,578,000 | 0.27% |
| RWC Asset Management LLP | 8,200,000 | $8,143,000 | 0.26% |